According to TheFly, UBS upgraded Southwest to ‘Neutral’ from ‘Sell’ with a price target of $36, while Melius Research upgraded the stock to ‘Hold’ from ‘Sell’ with a price target of $34.
Cruise operators, including Carnival, Royal Caribbean Group (RCL), and Norwegian Cruise Line Holdings (NCLH), reported broadly strong revenue and profit growth last year, driven by robust demand and higher pricing.
CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.
President Donald Trump's trade tariffs and persisting inflation in the United States have pressured the outlook for businesses, particularly consumer retailers.
Earlier this week, Citi said that it expects the company to post "decent results but guide below consensus, driven by worse consumer mix and NAND underutilization charges.”
As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.
The deal aligns with Nvidia’s broader push into synthetic data generation, seen at GTC 2025, which helps developers train AI models with highly customized datasets.
For many investors, the goal of achieving financial independence or building wealth in the long run focuses around strategies like dividend reinvestment plans and
West indicated that Boeing’s cash burn is easing in the current quarter, and its factories are improving as the company emerges from several manufacturing and safety crises.
The Oppenheimer analyst reportedly noted that he is adopting a more cautious stance on his coverage universe and is shifting his focus on stocks with the best secular growth stories.
A CPUC spokesperson told Reuters that the permit does not authorize the company to provide rides in autonomous vehicles or allow Tesla to open a ride-hailing service to the public.
Bank of America (BofA) said Nvidia is “deepening its competitive moat,” while JPMorgan noted that the company’s “aggressive roadmap” keeps it “1-2 steps ahead of its competitors.”
CCV is privately owned and is an international payment solutions provider serving more than 600,000 businesses with end-to-end payment solutions in Europe.
Last week, Telsey Advisory lowered the price target to $55 from $65 with a Market Perform rating following the company’s disappointing holiday sales and Q4 guidance
A Betaville report suggested Altimmune has begun a strategic review with an adviser, with speculation that three major pharmaceutical firms may be involved.
According to a Reuters report, a U.S. judge dismissed a lawsuit that accused the company of using an algorithm making its private-label products cheaper than other goods.
